Sucampo Pharmaceuticals, Inc.
SCMP
SCMP was delisted on the 12th of February, 2018.
149 hedge funds and large institutions have $384M invested in Sucampo Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 61 increasing their positions, 49 reducing their positions, and 25 closing their positions.
25% more call options, than puts
Call options by funds: $1.01M | Put options by funds: $807K
24% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 49
3% less funds holding
Funds holding: 154 → 149 (-5)
16% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 25
18% less capital invested
Capital invested by funds: $470M → $384M (-$86.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GAM
Gotham Asset Management
New York
|
+$7.66M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$6.2M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$5.45M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$5.45M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$32.1M |
| 2 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$10.9M |
| 3 |
Morgan Stanley
New York
|
-$8.21M |
| 4 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$7.14M |
| 5 |
State Street
Boston,
Massachusetts
|
-$6.27M |
SCMP Hedge Fund Activity: Q4 2015 in Review
149 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q4 2015, worth a combined $384M — down 18% from $470M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of SCMP and 21 opened new positions — a net loss of 4 holders — while 49 trimmed existing stakes and 61 added.
The largest buyer was Gotham Asset Management, adding an estimated $7.66M. The largest seller was Granahan Investment Management, exiting entirely with an estimated $32.1M sold.
- 149 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q4 2015, down from 154 in Q3 2015.
- Funds reported $384M of Sucampo Pharmaceuticals, Inc. stock for Q4 2015, down 18% quarter-over-quarter.
- 21 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q4 2015 and 25 closed out, a net change of -4 holders.
- The largest Sucampo Pharmaceuticals, Inc. buyer in Q4 2015 was Gotham Asset Management, an estimated $7.66M added.
- The largest Sucampo Pharmaceuticals, Inc. seller in Q4 2015 was Granahan Investment Management, an estimated $32.1M sold.
Based on aggregated 13F filings for Q4 2015.